OR21-01 Pre-treatment Blood Transcriptome Predicts First-year Growth And IGF-I Response To Somapacitan Treatment In Children With GH Deficiency

Disclosure: T. Garner: Grant Recipient; Self; Novo Nordisk. P.E. Clayton: Grant Recipient; Self; Novo Nordisk. M. Hojby: Employee; Self; Novo Nordisk. Stock Owner; Self; Novo Nordisk. P. Murray: Grant Recipient; Self; Novo Nordisk. A. Stevens: Grant Recipient; Self; Novo Nordisk. Background: Growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Garner, Terence, Clayton, Peter Ellis, Hojby, Michael, Murray, Philip, Stevens, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555074/
http://dx.doi.org/10.1210/jendso/bvad114.1519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555074/
http://dx.doi.org/10.1210/jendso/bvad114.1519

Ejemplares similares